Skip to content
Home/Companies/Biotech/arcoris bio

arcoris bio

Biotech·Switzerland·Active·1yr hold
Entry
2025
Hold
1yr
Status
Active

Who owns arcoris bio?

arcoris bio is a Swiss Biotech company, currently owned by ZEISS Ventures since 2025.

Hand-verified · updated 2026-07-03

Open JSON · CC-BY
ZEISS Ventures
Investor
ZEISS Ventures
ZEISS Ventures CVC · 2019 · Evergreen

Key facts

HQSwitzerland
SectorBiotech
StatusActive

More from ZEISS Ventures CVC

Other portfolio companies in the same fund.

Custom Surgical
Custom Surgical
Active
MedTechGermany· 2026
Maculaser
Active
MedTechFinland· 2026
Lidrotec
Active
Deep TechGermany· 2025
Odne
Active
MedTechSwitzerland· 2025
Surgify Medical
Active
MedTechFinland· 2025
Creal
Active
Deep TechSwitzerland· 2024

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Abbisko Healthcare
Active
The Carlyle GroupChina
Adagene
Active
General AtlanticChina
Advanced Cell Diagnostics
Active
Summit PartnersUS
Akero Therapeutics
Akero Therapeutics
Active
General AtlanticUS
Aldevron
Aldevron
Active
TA AssociatesUS
Alloy Therapeutics
Alloy Therapeutics
Active
Mubadala CapitalUS

Questions

Who owns arcoris bio?

arcoris bio is currently owned by ZEISS Ventures, through ZEISS Ventures CVC, since 2025.

When did ZEISS Ventures acquire arcoris bio?

ZEISS Ventures acquired arcoris bio in 2025.

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue